Athens Research and Technology, Inc.  

110 Trans Tech Drive
Athens,  GA  30601

United States
https://sales.athensresearch.com/

• Booth: 2544

Athens Research & Technology manufactures highly pure, highly active human and animal proteins for ongoing use worldwide by researchers, and for life sciences product manufacturing in the pharmaceutical, diagnostic, and calibration & control verticals. We are driven by People, Purpose, and Proteins. As a small company with a vital impact in the biotech world, we are deeply committed to our team, our community, and the critical nature of the components we produce. We take pride in being your trusted source for a wide range of proteins, knowing the importance they hold in your research or manufacturing projects. When you choose ART, you can have confidence in receiving not only high-quality products but also expert support tailored to your specific needs. From our humble beginnings in 1986 as one of the University of Georgia’s first start-ups to our recent consecutive Globe Awards for global exports, ART is a small company that is making a difference locally and globally.

 Press Releases

• Georgia Exporter of the Year: Athens Research and Technology (Apr 26, 2023)
  In 2022, the Georgia Department of Economic Development’s International Trade Division recognized Athens Research and Technology as an Exporter of the Year in the small company category. This company was one of three chosen from the 2022 GLOBE Award winners for their success in global exporting.
  
  Read More. 

• John Mitchell, CEO of Athens Research and Technology, on Their Life Science Business in Athens (Apr 26, 2023)
  CEO, John Mitchell, talks about the company and plans for growth in the future.
  
  Watch the interview here.

• Athens Research and Technology Named Small Business of the Year by Athens Area Chamber of Commerce (Jul 18, 2023)

  Athens, GA - Athens Research and Technology (ART) has been named Small Business of the Year by the Athens Area Chamber of Commerce. The award was presented at the 119th Annual Meeting in historic Athens, Georgia.

   

  ART was selected for this prestigious award based on its outstanding contributions to the local community, commitment to innovation, and dedication to excellence in the biotech and life science industries. Founded in 1986 out of the University of Georgia, ART specializes in the production and distribution of high-quality research reagents, serving customers in over 70 countries around the world.

• Georgia Trend: An Optimistic Outlook (Jul 18, 2023)

  Small Companies, Big Success
  
  Two years into his job as CEO of Athens Research and Technology (ART), John Mitchell is still impressed by the variety of resources Georgia offers companies.

  “We get more help and support in this state than anywhere else I have worked,” he says. “Our international sales went up 39% in 12 months, and that’s because of both local and state resources.”

  Named small company Exporter of the Year for 2022 by GDEcD, ART purifies critical proteins, from both human and animal sources, for use by researchers to better understand disease and develop new treatments, Mitchell explains. Proteins are found in blood and plasma, which may contain hundreds of proteins. Researchers seek particular proteins which ART is able to identify, extract and purify at scale.

  The company was founded in 1986 by noted UGA biochemist James Travis and three local pathologists. It began shipping internationally almost before it was established, Mitchell says. It has 22 employees (soon to be 28) and now ships directly to some 30 countries and has distributors in others. Mitchell credits the more than 1,500 research papers over the past 10 years that have named ART as their source of proteins for helping to spread the word about the company.
  
  Read more: https://www.georgiatrend.com/2023/06/27/an-optimistic-outlook/

 Additional Info